ImmunologyTheranosticsPeer-reviewed
Secreted Clever-1 Modulates T Cell Responses and Impacts Cancer Immunotherapy Efficacy
Stuart Prince, Miro Viitala, Riikka Sjöroos…·Maija Hollmén
This study identifies a secreted form of Clever-1 that suppresses T cell responses and reduces anti-PD-1 efficacy in cancer, suggesting it as a therapeutic target and biomarker.
9 citations